Found: 84
Select item for more details and to access through your institution.
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2556, doi. 10.3390/cancers16142556
- By:
- Publication type:
- Article
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus‐based position paper from an ad hoc expert panel.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 2, p. 1, doi. 10.1002/hon.3255
- By:
- Publication type:
- Article
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00991-2
- By:
- Publication type:
- Article
Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3215
- By:
- Publication type:
- Article
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus‐based position paper from an ad hoc expert panel.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 795, doi. 10.1002/hon.3172
- By:
- Publication type:
- Article
VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 756, doi. 10.1002/jha2.708
- By:
- Publication type:
- Article
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 1, p. 14, doi. 10.1159/000527284
- By:
- Publication type:
- Article
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.987643
- By:
- Publication type:
- Article
Everyone is entitled to his or her own opinion but not to their own facts*.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1290, doi. 10.1111/bjh.18035
- By:
- Publication type:
- Article
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 1, p. 30, doi. 10.1159/000517207
- By:
- Publication type:
- Article
New Markers of Disease Progression in Myelofibrosis.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5324, doi. 10.3390/cancers13215324
- By:
- Publication type:
- Article
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes.
- Published in:
- Genes, 2021, v. 12, n. 8, p. 1271, doi. 10.3390/genes12081271
- By:
- Publication type:
- Article
Critical concepts and management recommendations for cutaneous T‐cell lymphoma: A consensus‐based position paper from the Italian Group of Cutaneous Lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 275, doi. 10.1002/hon.2832
- By:
- Publication type:
- Article
Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2552, doi. 10.3390/cancers13112552
- By:
- Publication type:
- Article
Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis – case report and systematic review of dabigatran use.
- Published in:
- VASA. Zeitschrift für Gefässkrankheiten, 2021, v. 50, n. 2, p. 151, doi. 10.1024/0301-1526/a000876
- By:
- Publication type:
- Article
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.034
- By:
- Publication type:
- Article
Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584541
- By:
- Publication type:
- Article
Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 9, p. 2960, doi. 10.1002/cam4.2946
- By:
- Publication type:
- Article
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0815-5
- By:
- Publication type:
- Article
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies.
- Published in:
- Clinical Transplantation, 2019, v. 33, n. 10, p. N.PAG, doi. 10.1111/ctr.13666
- By:
- Publication type:
- Article
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0225-5
- By:
- Publication type:
- Article
Constitutive STAT5 phosphorylation in CD34<sup>+</sup> cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220189
- By:
- Publication type:
- Article
Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2102, doi. 10.1002/1878-0261.12387
- By:
- Publication type:
- Article
European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1062, doi. 10.1002/ajh.24837
- By:
- Publication type:
- Article
Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 6, p. 554, doi. 10.1111/ejh.12768
- By:
- Publication type:
- Article
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 918, doi. 10.1002/ajh.24442
- By:
- Publication type:
- Article
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 709, doi. 10.1002/ajh.24388
- By:
- Publication type:
- Article
Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156990
- By:
- Publication type:
- Article
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 7, p. 1657, doi. 10.1002/ijc.29920
- By:
- Publication type:
- Article
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis.
- Published in:
- Stem Cells, 2016, v. 34, n. 4, p. 1123, doi. 10.1002/stem.2285
- By:
- Publication type:
- Article
Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 140, doi. 10.1111/bjh.13471
- By:
- Publication type:
- Article
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 362, doi. 10.1007/s11899-015-0281-2
- By:
- Publication type:
- Article
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1091, doi. 10.2147/OTT.S31916
- By:
- Publication type:
- Article
JAK2 Exon 14 Skipping in Patients with Primary Myelofibrosis: A Minor Splice Variant Modulated by the JAK2-V617F Allele Burden.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0116636
- By:
- Publication type:
- Article
An Immune Dysregulation in MPN.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 331, doi. 10.1007/s11899-014-0227-0
- By:
- Publication type:
- Article
Enhanced Expression of Stim, Orai, and TRPC Transcripts and Proteins in Endothelial Progenitor Cells Isolated from Patients with Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091099
- By:
- Publication type:
- Article
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 4, p. 513, doi. 10.1002/cncr.28441
- By:
- Publication type:
- Article
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The ERCC2 Gln/ Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 424, doi. 10.1111/bjh.12376
- By:
- Publication type:
- Article
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 229, doi. 10.1111/bjh.12375
- By:
- Publication type:
- Article
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 688, doi. 10.1111/bjh.12332
- By:
- Publication type:
- Article
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 185, doi. 10.1002/ajh.23372
- By:
- Publication type:
- Article
<i>JAK2</i> V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059791
- By:
- Publication type:
- Article
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 875, doi. 10.1007/s00277-012-1445-y
- By:
- Publication type:
- Article
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 562, doi. 10.1002/ajh.23169
- By:
- Publication type:
- Article
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035631
- By:
- Publication type:
- Article
Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice.
- Published in:
- Current Hematologic Malignancy Reports, 2012, v. 7, n. 1, p. 50, doi. 10.1007/s11899-011-0109-7
- By:
- Publication type:
- Article
Cell-cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 7, p. 1817, doi. 10.1002/jcb.23100
- By:
- Publication type:
- Article